153 related articles for article (PubMed ID: 32831826)
1. Diagnostic Value of Plasma miR-181b, miR-196a, and miR-210 Combination in Pancreatic Cancer.
Liu G; Shao C; Li A; Zhang X; Guo X; Li J
Gastroenterol Res Pract; 2020; 2020():6073150. PubMed ID: 32831826
[TBL] [Abstract][Full Text] [Related]
2. Clinical Significance of Color Ultrasound, MRI, miR-21, and CA199 in the Diagnosis of Pancreatic Cancer.
Yu J; Yang X; Wu H; Li J
J Oncol; 2021; 2021():2380958. PubMed ID: 34367281
[TBL] [Abstract][Full Text] [Related]
3. Serum miR-10a-5p and miR-196a-5p as non-invasive biomarkers in non-small cell lung cancer.
Bao M; Pan S; Yang W; Chen S; Shan Y; Shi H
Int J Clin Exp Pathol; 2018; 11(2):773-780. PubMed ID: 31938164
[TBL] [Abstract][Full Text] [Related]
4. Combination of plasma microRNAs with serum CA19-9 for early detection of pancreatic cancer.
Liu J; Gao J; Du Y; Li Z; Ren Y; Gu J; Wang X; Gong Y; Wang W; Kong X
Int J Cancer; 2012 Aug; 131(3):683-91. PubMed ID: 21913185
[TBL] [Abstract][Full Text] [Related]
5. Coagulation parameters for the differential diagnosis of pancreatic cancer in the early stage: a retrospective study.
Jiaao L; Wanli G; Kai Z; Feng G; Yunpeng P
Eur J Med Res; 2023 Oct; 28(1):436. PubMed ID: 37848965
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of combining preoperative inflammatory markers ratios with CA199 for patients with early-stage pancreatic cancer.
Gu Y; Hua Q; Li Z; Zhang X; Lou C; Zhang Y; Wang W; Cai P; Zhao J
BMC Cancer; 2023 Mar; 23(1):227. PubMed ID: 36899319
[TBL] [Abstract][Full Text] [Related]
7. [Expression and clinical significance of plasma small RNA in patients with pancreatic cancer].
Pan W; Tang W; Yuan W; Yu Q; Zuo W; Xu C; Ma J
Zhonghua Zhong Liu Za Zhi; 2014 May; 36(5):351-4. PubMed ID: 25030590
[TBL] [Abstract][Full Text] [Related]
8. Differential signature of fecal microRNAs in patients with pancreatic cancer.
Ren Y; Gao J; Liu JQ; Wang XW; Gu JJ; Huang HJ; Gong YF; Li ZS
Mol Med Rep; 2012 Jul; 6(1):201-9. PubMed ID: 22504911
[TBL] [Abstract][Full Text] [Related]
9. Long Intergenic Non-Coding 00162 as Diagnostic Biomarker for Early-Stage Pancreatic Cancer.
Chen M; Lu Y; Qin S; Hu Z; Chen H; Lu L; Mo C; Zhang X; Huang J; Qin X
Ann Clin Lab Sci; 2022 Jul; 52(4):533-543. PubMed ID: 36197769
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-196a-5p is a potential prognostic marker of delayed lymph node metastasis in early-stage tongue squamous cell carcinoma.
Maruyama T; Nishihara K; Umikawa M; Arasaki A; Nakasone T; Nimura F; Matayoshi A; Takei K; Nakachi S; Kariya KI; Yoshimi N
Oncol Lett; 2018 Feb; 15(2):2349-2363. PubMed ID: 29434944
[TBL] [Abstract][Full Text] [Related]
11. Combined use of Serum miR-499a-5p and CA199 Increases the Diagnostic Sensitivity of Pancreatic Cancer.
Shi Q; Feng K; Xia L; Wang C; Zhu J
Clin Lab; 2019 Nov; 65(11):. PubMed ID: 31710444
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Plasma MicroRNAs as Diagnostic and Prognostic Biomarkers in Pancreatic Adenocarcinoma: miR-196a and miR-210 Could Be Negative and Positive Prognostic Markers, Respectively.
Yu Q; Xu C; Yuan W; Wang C; Zhao P; Chen L; Ma J
Biomed Res Int; 2017; 2017():6495867. PubMed ID: 28466015
[No Abstract] [Full Text] [Related]
13. Circulating microRNA-196a/b are novel biomarkers associated with metastatic gastric cancer.
Tsai MM; Wang CS; Tsai CY; Huang CG; Lee KF; Huang HW; Lin YH; Chi HC; Kuo LM; Lu PH; Lin KH
Eur J Cancer; 2016 Sep; 64():137-48. PubMed ID: 27420607
[TBL] [Abstract][Full Text] [Related]
14. Plasma-Derived Exosomal ALIX as a Novel Biomarker for Diagnosis and Classification of Pancreatic Cancer.
Yang J; Zhang Y; Gao X; Yuan Y; Zhao J; Zhou S; Wang H; Wang L; Xu G; Li X; Wang P; Zou X; Zhu D; Lv Y; Zhang S
Front Oncol; 2021; 11():628346. PubMed ID: 34026608
[TBL] [Abstract][Full Text] [Related]
15. Combined determination of circulating miR-196a and miR-196b levels produces high sensitivity and specificity for early detection of oral cancer.
Lu YC; Chang JT; Huang YC; Huang CC; Chen WH; Lee LY; Huang BS; Chen YJ; Li HF; Cheng AJ
Clin Biochem; 2015 Feb; 48(3):115-21. PubMed ID: 25485932
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-196a and -196b as Potential Biomarkers for the Early Detection of Familial Pancreatic Cancer.
Slater EP; Strauch K; Rospleszcz S; Ramaswamy A; Esposito I; Klöppel G; Matthäi E; Heeger K; Fendrich V; Langer P; Bartsch DK
Transl Oncol; 2014 Aug; 7(4):464-71. PubMed ID: 24956938
[TBL] [Abstract][Full Text] [Related]
17. The diagnostic and prognostic values of microRNA-196a in cancer.
Xiong M; Wang P; Pan B; Nie J; Wang S; He B
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33289788
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-181b expression in prostate cancer tissues and its influence on the biological behavior of the prostate cancer cell line PC-3.
He L; Yao H; Fan LH; Liu L; Qiu S; Li X; Gao JP; Hao CQ
Genet Mol Res; 2013 Apr; 12(2):1012-21. PubMed ID: 23613247
[TBL] [Abstract][Full Text] [Related]
19. Plasma exosome miR-196a and miR-1246 are potential indicators of localized pancreatic cancer.
Xu YF; Hannafon BN; Zhao YD; Postier RG; Ding WQ
Oncotarget; 2017 Sep; 8(44):77028-77040. PubMed ID: 29100367
[TBL] [Abstract][Full Text] [Related]
20. LncRNA DLX6-AS1 promoted cancer cell proliferation and invasion by attenuating the endogenous function of miR-181b in pancreatic cancer.
An Y; Chen XM; Yang Y; Mo F; Jiang Y; Sun DL; Cai HH
Cancer Cell Int; 2018; 18():143. PubMed ID: 30250401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
